CARSON CITY, Nev., Aug. 25, 2006 (PRIMEZONE) -- Avitech Lifesciences Inc. (Other OTC:AVLF) announced today that Avitol, the homeopathic product formulated to aid against the Avian Flu, is now available for distribution. Avitol is based on various acid derivatives as well as other active ingredients including high potency anti-oxidants. It has been developed with an advanced delivery system and is intended to offer a homeopathic alternative to most virulent strains of Avian Flu.
Avitech Lifesciences Inc. is in the process of establishing an e-commerce website to market the product throughout Europe and Asia. There is an increased awareness worldwide regarding the Avian Flu Virus and the alarming potential of a pandemic. The Company is extremely pleased to make available a homeopathic product that has the potential to protect against this feared virus.
Avitol, produced in capsule form, will be available for purchase on the e-commerce site when it is up and running. The Company is also seeking long term distributorship for Avitol. Interested parties are welcome to submit any inquiries regarding Avitol to our website at www.avitechls.com .
The Company further mentioned that an additional website currently under construction to market their full line of homeopathic products recently introduced is near completion.
About Avitech Lifesciences Inc.
Avitech Lifesciences Inc. is a firm focused on health and life sciences industry. Avitech helps entrepreneurs accelerate their business development by investing early in the company's development and taking an active role in its day to day operations by acting as collaborative partners with the companies we bring on board. Although Avitech Lifesciences Inc. primary mandate is health and life sciences sector the company's mandate will allow it to look at all investments to increase shareholder value
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Statements in this release that are forward-looking statements are based on current expectations and assumptions that are subject to known and unknown risks, uncertainties, or other factors which may cause actual results, performance, or achievements of the company to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Actual results could differ materially because of factors such as the effect of general economic and market conditions, entry into markets with vigorous competition, market acceptance of new products and services, continued acceptance of existing products and services, technological shifts, and delays in product development and related product release schedules, any of which may cause revenues and income to fall short of anticipated levels. All information in this release is as of the date of this release. The company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the company's expectations.